Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes

PURPOSE: The clinical relevancy of the 7-subtype classification of triple-negative breast cancer (TNBC) reported by Lehmann and Bauer et al is unknown. We investigated the clinical relevancy of TNBC heterogeneity by determining pathological complete response (pCR) rates after neoadjuvant chemotherap...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Masuda, Hiroko, Baggerly, Keith A., Wang, Ying, Zhang, Ya, Gonzalez-Angulo, Ana Maria, Meric-Bernstam, Funda, Valero, Vicente, Lehmann, Brian D., Pietenpol, Jennifer A., Hortobagyi, Gabriel N., Symmans, W. Fraser, Ueno, Naoto T.
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3813597/
https://ncbi.nlm.nih.gov/pubmed/23948975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-0799
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares